Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects With Ocular Hypertension or Primary Open-Angle Glaucoma
Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s242932
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2020
Authors
Publisher
Informa UK Limited